Company profile
Link Biologics
Link Biologics is a University of Manchester spin-out company developing Link_TSG6 to treat inflammatory and degenerative disorders
Financial period: 1 May 2024 to 30 Apr 2025
Reference milestones and recent Companies House filing stream events.
Next confirmation statement due date
Next accounts due date
Last confirmation statement made up date
Last accounts made up date
Company registered at Companies House
Link Biologics operates a biotechnology company that develops treatments for inflammatory and degenerative diseases.
Link Biologics is a spinout company from the University of Manchester, developing Link_TSG6 as a protein biologic for inflammatory and tissue degenerative disorders (e.g. dry eye disease and osteoarthritis); company founded in 2020 and launched in June 2021.
No significant impacts noted as yet.
None as yet.
